Abstract
COMPARATIVE HISTOPATHOLOGICAL EFFECTS OF METFORMIN AND GLIBENCLAMIDE ON PANCREAS IN ALLOXAN INDUCED DIABETIC ALBINO RATS

Nuzhat Bashir, Aijaz Ahmad Patloo* and Nadia Bashir

ABSTRACT

Introduction: Diabetes mellitus is a systemic metabolic disorder characterised by elevated blood glucose levels due to absolute or relative deficiency of insulin secretion from pancreatic β-cells. It is implicated in oxidative stress which induces insulin resistance in the peripheral tissue and impairs insulin secretion from pancreatic beta cells. In this study we evaluated the comparative histopathological effect of Metformin and Glibenclamide on Pancreas in Alloxan induced diabetic rats. Material and Methods: The present study was conducted on 24 experimental animals which were divided into four groups of with 6 rats in each group and were treated accordingly Group 1:Healthy control (HC) rats, Group 2: Diabetic control (DC) rats,Group 3: Diabetes mellitus (DM) + Metformin(M) rats,Group 4: Diabetes mellitus (DM) + Glibenclamide(G) rats.After 28 days of treatment rats were sacrificed and blood glucose and body weight was determined along with histopathological study of pancreas. Result: The results showed that both Metformin and glibenclamide reversed Alloxan induced diabetic histopathological changes in Pancreas in Albino rats. Conclusion: The present results demonstrate that normoglycemia with metformin and glibenclamide ameliorates diabetic induced histopathological lesions in Pancreas.

Keywords: Diabetes, histopathology, Pancreas, Metformin, Glibenclamide.


[Full Text Article]   [Download Certificate]

Indexing

Best Article Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: New Impact Factor 2026

    EJBPS Impact Factor has been Increased from  7.482 to 8.181 for Year 2026.

  • EJBPS: FEBRUARY ISSUE PUBLISHED

    FEBRUARY 2026 Issue has been successfully launched on 1 FEBRUARY 2026.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

Google Scholar Index Copernicus Indian Science Publications Urlich's Periodicals Directory, Proquest, UK (In Process) Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) UDLedge Science Citation Index Doi-Digital Online Identifier InfoBase Index (In Process) Universal Impact Factor SJIF Impact Factor Scholar Article Impact Factor, SAIF CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Academia Cosmos Impact Factor Eurasian Scientific Journal Index (ESJI) Impact Factor Services For International Journals (IFSIJ) Jour Informatics (Under Process) Global Impact Factor (GIF) (0.377) International Innovative Journal Impact Factor (IIJIF) Academia Science Library Index, Dubai, United Arab Emirates IP Indexing (IP Value 3.77) Web of Science Group (Under Process) Directory of Research Journals Indexing Scope Database Doi-Digital Online Identifier ISSN National Centre Zenodo Indexing International CODEN Service, USA

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT